American Portfolios Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$4.29K Hold
72
﹤0.01% 2881
2022
Q2
$4.04K Sell
72
-25
-26% -$1.64K ﹤0.01% 2917
2022
Q1
$7.16K Hold
97
﹤0.01% 2824
2021
Q4
$7K Sell
97
-200
-67% -$14.5K ﹤0.01% 2767
2021
Q3
$22.8K Hold
297
﹤0.01% 2225
2021
Q2
$23K Hold
297
﹤0.01% 2157
2021
Q1
$18.3K Buy
297
+97
+49% +$6.14K ﹤0.01% 2111
2020
Q4
$13K Sell
200
-73
-27% -$4.2K ﹤0.01% 1993
2020
Q3
$13.5K Buy
273
+8
+3% +$413 ﹤0.01% 1860
2020
Q2
$12.6K Buy
265
+212
+400% +$10.2K ﹤0.01% 1837
2020
Q1
$2.25K Buy
+53
New +$2.62K ﹤0.01% 2354
2019
Q4
Sell
-978
Closed -$50K 2877
2019
Q3
$50K Buy
978
+878
+878% +$41.8K ﹤0.01% 1283
2019
Q2
$4.23K Buy
+100
New +$4.34K ﹤0.01% 2234

Other funds holding GMED

American Portfolios Advisors's GMED Position: Q3 2022 in Review

American Portfolios Advisors held its Globus Medical (GMED) position steady in Q3 2022 at 72 shares worth $4.29K. The position accounts for ﹤0.01% of the portfolio, ranked #2881.

American Portfolios Advisors first reported a position in GMED in Q2 2019 and has held it in 13 quarters since. The position peaked at $50K in Q3 2019. 370 funds tracked by Wall St. Rank hold GMED as of Q3 2022.

  • American Portfolios Advisors held 72 shares of Globus Medical worth $4.29K as of Q3 2022.
  • American Portfolios Advisors left its Globus Medical share count unchanged in Q3 2022.
  • Globus Medical made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2881 holding.
  • American Portfolios Advisors first reported a position in Globus Medical in Q2 2019 and has held it in 13 quarters since.
  • American Portfolios Advisors's Globus Medical position peaked at $50K in Q3 2019.
  • 370 funds tracked by Wall St. Rank held Globus Medical as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.